Cancer Survivor Max Penzer Pushes AI for Pediatric Research

Max Penzer was just 10 years old when doctors diagnosed him with osteosarcoma, a rare bone cancer in his right leg. Now 20 and cancer-free for a decade, the Melville resident is fighting for other kids who might not be as lucky.

On September 18, Penzer will join advocates at Capitol Hill for Climb the Hill Day. He's pushing for funding for the Accelerating Innovation for Kids with Cancer Act, legislation that would harness federal AI tools to improve pediatric cancer research and treatment.

The stakes are personal. While Penzer responded well to treatment, he knows that only 70% of osteosarcoma patients do. That statistic drives his advocacy work today.

"Now, what can I do to help the people that don't respond in the advocacy front?" Penzer asks. The answer lies in artificial intelligence.

The challenge is data. Pediatric cancer information is far less accessible than adult data, and AI systems need children's specific medical information to identify patterns and develop better treatments. That's where the proposed legislation comes in.

The act would create a coordinated effort to use federal AI resources specifically for pediatric cancer research and clinical care. The technology could analyze a child's unique genetic makeup to understand their specific disease better and predict which treatments might work best.

Why This Inspires

Penzer admits he tried to distance himself from decisions during his own treatment. He didn't want to know what was happening or be involved in choosing his care path. But that experience of feeling helpless as a child fuels his determination to give future patients better options.

His decade of being disease-free represents a major milestone. But instead of simply celebrating his own survival, he's channeling that good fortune into action for others who face tougher odds.

The AI tools he's advocating for could transform how doctors approach pediatric cancers. By analyzing patient-specific genomes and transcriptomes, artificial intelligence could help researchers understand why some children respond to treatment while others don't. That knowledge could lead to personalized treatment plans that save more young lives.

Penzer's message to lawmakers is clear: pediatric cancer research needs the same cutting-edge AI tools that are revolutionizing other fields of medicine. Kids deserve treatments designed specifically for their bodies and their cancers, not scaled-down versions of adult protocols.

His advocacy represents hope for families facing the unimaginable stress of a childhood cancer diagnosis. Better data, smarter tools, and more targeted treatments could mean more kids get to celebrate their own 10-year milestones.